✦ LIBER ✦

Incentives for paediatric drug development in Europe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonclinical safety in paediatric drug de

✍ Ridings, Jim 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Developing Personalized Medicine Drugs -

✍ Noweski, M.; Hessel, F.P.; Walendzik, A.; Jahn, R.; Wasem, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Incentives for orphan drug research and

✍ Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Sheryl L Szeinbach; Jay Visaria 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 177 KB

Fungal metabolites: structural diversity

✍ Hendrik Greve; Ietidal E. Mohamed; Alexander Pontius; Stefan Kehraus; Harald Gro 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 561 KB

On the need for juvenile animal studies

✍ Dinah M. Duarte; Beatriz Silva-Lima 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Drug use patterns for the prevention of

✍ Winnie Vogt; Stephanie Läer 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 134 KB